Thomson Healthcare, a unit of The Thomson Corp., last week launched the NeoFax neonatal drug dosing solution. NeoFax helps physicians, nurses and pharmacists more quickly access information about neonatal drug dosing and parenteral nutrition with the goal of ensuring that physicians are administering the correct medication and proper dosage to their youngest patients.

NeoFax's collection of tools consists of alerts, an interaction checker and a patient-specific dosing calculator. It includes more than 185 substances and a set of clinical decision support modules for patient specific dosing and parenteral nutrition order entry for neonates. NeoFax is available in a variety of formats, including print, PDA and a Web-based application designed for hospital neonatal intensive care units.

Thomson recently acquired NeoFax, which launched its first neonatal dosing and nutrition manual was released in 1987. With the strength of a powerful parent company behind it, NeoFax is positioned for growth during its 20th anniversary year and beyond, especially since malpractice remains a prominent issue within the medical community. Thomson is well-known for being at the forefront of electronic-based solutions and the professional publishing powerhouse will likely work its magic on NeoFax.